215 related articles for article (PubMed ID: 37842460)
1. Emergence of Rhino-Orbito-Cerebral Mucormycosis in Peru: Impact of the COVID-19 Pandemic.
Cumpa-Quiroz R; Elguera-Falcón F; Guevara-Lazo DR
Cureus; 2023 Sep; 15(9):e45240. PubMed ID: 37842460
[TBL] [Abstract][Full Text] [Related]
2. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
3. Rhino-orbito-cerebral mucormycosis in patients with uncontrolled diabetes: A case series.
Al Hassan F; Aljahli M; Molani F; Almomen A
Int J Surg Case Rep; 2020; 73():324-327. PubMed ID: 32738774
[TBL] [Abstract][Full Text] [Related]
4. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
[TBL] [Abstract][Full Text] [Related]
5. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
Mehfooz S; Mehrotra N; Usmani T; Raj V
Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
[TBL] [Abstract][Full Text] [Related]
6. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
[TBL] [Abstract][Full Text] [Related]
7. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
8. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
9. C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
B H S; Bidkar V; Prathipati K; Dabhekar S; Selvaraj K; G D
Cureus; 2024 Apr; 16(4):e59007. PubMed ID: 38800245
[TBL] [Abstract][Full Text] [Related]
10. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
[TBL] [Abstract][Full Text] [Related]
11. Radiological Manifestations of Rhino-Orbito-Cranial Mucormycosis in COVID-19 Patients Correlated With Pathological and Clinical Outcomes and Emphasis on Magnetic Resonance Imaging-Based Scoring System.
Patil C; Kumar A; Battula V; Kumar P; Kollu R; Kotamraju S; Nethi Balingari BL; Reddy S; Ravula S; Reddy AR
Cureus; 2023 Mar; 15(3):e35745. PubMed ID: 37020477
[TBL] [Abstract][Full Text] [Related]
12. Mucor in a Viral Land: A Tale of Two Pathogens.
Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
[TBL] [Abstract][Full Text] [Related]
13. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
[TBL] [Abstract][Full Text] [Related]
14. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.
Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B
Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988
[TBL] [Abstract][Full Text] [Related]
15. Post-COVID-19 rhino-orbito-cerebral mucormycosis-A clinico-mycological study from North India.
Taneja J; Chatterjee K; Sasidharan J; Abbas SZ; Rai AK; Raychaudhury S; Das B; Das A
Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37442616
[TBL] [Abstract][Full Text] [Related]
16. Rhino-Orbito-Cerebral Mucormycosis: A Challenging Case.
El Hakkouni A; Harrar S; Hachimi A; Mezouari M; Moutaj R
Cureus; 2023 Sep; 15(9):e44768. PubMed ID: 37809164
[TBL] [Abstract][Full Text] [Related]
17. Various Treatment Modalities in COVID-19 Associated Facial Mucormycosis and the Need for its Surgical Management: A Systematic Review.
Chopra S; Setiya S; Waknis PP; Kale L; Tidke S
J Maxillofac Oral Surg; 2023 Mar; ():1-22. PubMed ID: 37362874
[TBL] [Abstract][Full Text] [Related]
18. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
Kumar S; Kumar H; Mali M; Meena BL
Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
[TBL] [Abstract][Full Text] [Related]
19. Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19.
Munhoz SD; Lellis RF; Reis APC; Del Negro GMB; Sousa MGT; Veasey JV
An Bras Dermatol; 2022; 97(4):501-504. PubMed ID: 35691738
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
